Skip to main content

Female Pseudohermaphroditism in 21-Hydroxylase Deficiency

  • Chapter
Gynecologic Endocrinology
  • 132 Accesses

Abstract

Congenital adrenal hyperplasia (CAH) is a family of inherited disorders of adrenal steroidogenesis. Each of these disorders has a characteristic pattern of hormonal abnormalities caused by an inherited deficiency of one of the several enzymes necessary for normal steroid synthesis. The most common form of CAH is caused by a deficiency of the 21-hydroxylase enzyme. Virilization is the foremost clinical symptom of 21-hydroxylase deficiency, as was first documented by the Neapolitan anatomist DeCrecchio in 1865.1 Since his report, numerous investigators have unravelled the mechanism of adrenal steroid synthesis and the associated enzyme defects responsible for CAH. A brief review of the mechanism and regulation of adrenal steroidogenesis is given below to aid in the understanding of the pathophysiology of CAH.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Decrecchio L: Sopra un caso di apparenze virile in una donna. Morgagni 7: 1951, 1865

    Google Scholar 

  2. Bongiovanni, AM, Eberlein WR, Goldman AS, et al: Disorders of adrenal steroid biogenesis. Recent Prog Horm Res 23: 375–439, 1967

    PubMed  CAS  Google Scholar 

  3. Finkelstein, M, Shaefer JM: Inborn errors of steroid biosynthesis. Physiol Rev 59: 353–406, 1979

    PubMed  CAS  Google Scholar 

  4. Ganong WF: Neurotransmitters and pituitary function: Regulation of ACTH secretion. FedProc 39: 2923–2930, 1980

    PubMed  CAS  Google Scholar 

  5. New MI, Seaman MP: Secretion rates of Cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 30: 361–371, 1970

    Article  PubMed  CAS  Google Scholar 

  6. Jost A: Embryonic sexual differentiation, in Jones HW, Scott WW (eds): Hermaphroditism, Genital Anomalies and Related Endocrine Disorders, 2nd ed. Baltimore, Williams & Wilkins, 1971, pp 16–64

    Google Scholar 

  7. Josso N, Picard JY, Tran D: The antiMullerian hormone. Recent Prog Horm Res 33: 117–168, 1977

    Google Scholar 

  8. Federman DD: Abnormal Sexual Development. Philadelphia, Saunders, 1968, pp 121–133

    Google Scholar 

  9. Binoux M, Pham-Huu-Trung MT, Gourmelen M, et al: Plasma ACTH in adrenogenital syndrome. Acta Paediatr (Stockh) 61: 269–270, 1972

    Google Scholar 

  10. Wilkins L: Adrenal disorders. II. Congenital virilizing adrenal hyperplasia. Arch Dis Child 37: 231–241, 1962

    Article  PubMed  CAS  Google Scholar 

  11. Rosenbloom AL, Smith DW: Varying expression for salt losing in related patients with congenital adrenal hyperplasia. Pediatrics 38: 215–219, 1966

    PubMed  CAS  Google Scholar 

  12. Muller W, Prader A, Kofler J, et al: Frequency of congenital adrenal hyperplasia. Padiatr Padol 14: 151–155, 1979

    PubMed  CAS  Google Scholar 

  13. Cohen JM: Salt-losing congenital adrenal hyperplasia. Pediatrics 44: 621–622, 1969

    PubMed  CAS  Google Scholar 

  14. Hirschfeld AJ, Fleshman JK: An unusually high incidence of salt-losing congenital adrenal hyperplasia in the Alaskan Eskimo. J Pediatr 75: 492–494, 1969

    Article  PubMed  CAS  Google Scholar 

  15. Pang S, Hotchkiss J, Drash AL, et al: Microfilter paper method for 17α-progesterone radioimmunoassay: Its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 45: 1003–1008, 1977

    Article  PubMed  CAS  Google Scholar 

  16. Lorenzen F, Pang S, New MI, et al: Hormonal phenotype and HLA-genotype in families of patients with congenital adrenal hyperplasia (21-hydroxylase deficiency). Pediatr Res 13: 1356–1370, 1979

    PubMed  CAS  Google Scholar 

  17. Pang S, Murphey W, Levine LS, et al: A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 55: 413–420, 1982

    Article  PubMed  CAS  Google Scholar 

  18. LaFranchi SH, Murphey WH, Foley TP Jr, et al: Neonatal hypothyroidism detected by the northwest regional screening program. Pediatrics 63: 180–191, 1979

    PubMed  CAS  Google Scholar 

  19. Dupont, B, Oberfield, SE, Smithwick EM, et al: Close genetic linkage between HLA and congenital adrenal hyperplasia (21 -hydroxylase deficiency). Lancet 2: 1309–1311, 1977

    Article  PubMed  CAS  Google Scholar 

  20. Levine LS, Zachmann M, New MI, et al: Genetic mapping of the 21-hydroxylase deficiency gene within the HLA linkage group. N Engl J Med 299: 911–915, 1978

    Article  PubMed  CAS  Google Scholar 

  21. Dupont B, Pollack MS, Levine LS, et al: Congenital adrenal hyperplasia, in Teraski PI (ed): Histocompatibility Testing. Los Angeles, UCLA Tissue Typing Laboratory, 1980, pp 693–706

    Google Scholar 

  22. Gutai JP, Kowarski AA, Migeon CJ: The detection of the heterozygous carrier for congenital adrenal hyperplasia. J Pediatr 90: 924–929, 1970

    Google Scholar 

  23. KnorrD, BidlingmaierF, Butenandt0,etal: Test for heterozygosity of congenital adrenal hyperplasia, in Lee PA, Plot- nick LP, Kowarski AA, Migeon CJ (eds): Congenital Adrenal Hyperplasia. Baltimore, University Park Press, 1977, pp 495–500

    Google Scholar 

  24. Lorenzen F, Pang S, New MI, et al: Studies of the C-21 and C-19 steroids and HLA genotyping in siblings and parents of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 50: 572–579, 1980

    Article  PubMed  CAS  Google Scholar 

  25. Grosse-Wilde HJ, Weil J, Albert E, et al: Genetic linkage studies between congenital adrenal hyperplasia and the HLA blood group system. Immunogenetics 8: 41–49, 1979

    Article  Google Scholar 

  26. Lejeune-Lenain C, Cantraine F, Dufrasnes, M, et al: An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia. Clin Endocrinol (Oxf) 12: 525–535, 1980

    Article  CAS  Google Scholar 

  27. Newmark S, Dluhy RG, Williams GH, et al: Partial 11- and 21-hydroxylase deficiencies in hirsute women. Am J Obstet Gynecol 127: 594–598, 1977

    Google Scholar 

  28. Rosenwaks Z, Lee PA, Jones GS, et al: An attenuated form of congenital virilizing adrenal hyperplasia. J Clin Endocrinol Metab 49: 335–339, 1979

    Article  PubMed  CAS  Google Scholar 

  29. Kohn B, Levine LS, Pollack MS, et al: Late-onset steroid 21-hydroxylase deficiency: A variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 55: 817–827, 1982

    Article  PubMed  CAS  Google Scholar 

  30. New MI, Lorenzen F, Pang S, et al: “Acquired” adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorder as congenital adrenal hyperplasia, J Clin Endocrinol Metab 48: 356–359, 1979

    Article  PubMed  CAS  Google Scholar 

  31. Morillo E, Gardner, LI: Genetics of acquired and congenital adrenal hyperplasia. Lancet 2: 202–203, 1979

    Article  PubMed  CAS  Google Scholar 

  32. Laron Z, Pollack MS, Zamir R, et al: Late onset 21-hydroxylase deficiency and HLA in the Ashkenzai population: A new allele at the 21-hydroxylase locus. Human Immunol 1: 55–66, 1980

    Article  CAS  Google Scholar 

  33. Blankstein J, Faiman C, Reyes FI, et al: Adult-onset familiar adrenal 21-hydroxylase deficiency. Am J Med 68: 441–448, 1980

    Article  PubMed  CAS  Google Scholar 

  34. Migeon CJ, Rosen waks, Z, Lee PA, et al: The attenuated form of congenital adrenal hyperplasia as an allelic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 51: 647–649, 1980

    Article  PubMed  CAS  Google Scholar 

  35. Pollack MS, Levine, LS, O’Neill GJ, et al: HLA linkage and B14, DR1, Bfs haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency, Am J Hum Genet 33: 540–550, 1981

    PubMed  CAS  Google Scholar 

  36. New MI, Dupont B, Pang S, et al: An update of congenital adrenal hyperplasia. Recent Prog Horm Res 37: 105–181, 1981

    PubMed  CAS  Google Scholar 

  37. Levine LS, Dupont B, Lorenzen F, et al: Cryptic 21 -hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 51: 1316–1324, 1980

    Article  PubMed  CAS  Google Scholar 

  38. Klouda PT, Harris R, Price DA: HLA and congenital adrenal hyperplasia. Lancet 2: 1046, 1978

    Article  Google Scholar 

  39. Pollack MS, Levine LS, Pang S, et al: Diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing. Lancet 1: 1107–1108, 1979

    Article  PubMed  CAS  Google Scholar 

  40. Levine, LS, Dupont, B, Lorenzen F, et al: Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab 53: 1193–1198, 1981

    Article  PubMed  CAS  Google Scholar 

  41. Jeffcoate TN A, Fliegner JRH, Russell SH, et al: Diagnosis of the adrenogenital syndrome before birth. Lancet 2: 553–555, 1965

    Article  PubMed  CAS  Google Scholar 

  42. New MI, Levine LS: Congenital adrenal hyperplasia, in Harris H, Hirschhorn K (eds): Advances in Human Genetics. New York, Plenum, 1973, pp 251–326

    Google Scholar 

  43. Pang S, Levine LS, Cederqvist LL, et al: Amniotic fluid concentrations of Δ5 and Δ4 steroids in fetuses with congenital adrenal hyperplasia due to 21-hydroxylase deficiency and in anencephalic fetuses. J Clin Endocrinol Metab 51: 223–229, 1980

    Article  PubMed  CAS  Google Scholar 

  44. Mininberg DT, Levine LS, New MI: Current concepts in congenital adrenal hyperplasia. Invest Urol 17: 169–175, 1979

    PubMed  CAS  Google Scholar 

  45. Bartter FC, Albright F, Forbes AP, et al: The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: An attempt to explain and correct its disordered hormonal pattern. J Clin Invest 30: 237–251, 1951

    Article  PubMed  CAS  Google Scholar 

  46. Rosier A, Levine LS, Schneider B, et al: The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab 45: 500–512, 1977

    Article  Google Scholar 

  47. Korth-Schutz S, Levine LS, New MI: Serum androgens in normal prepubertal and pubertal children and in children with precocious adrenarche. J Clin Endocrinol Metab 42: 117–124, 1976

    Article  PubMed  CAS  Google Scholar 

  48. New MI, Peterson RE: Disorders of aldosterone secretion in childhood. Pediatr Clin North Am 13: 43–58, 1966

    PubMed  CAS  Google Scholar 

  49. New MI, Dupont B, Grumbach K, et al: Congenital adrenal hyperplasia and related conditions, in Stanbury JB, Wyn- gaarden JB, Frederickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Disease, 5th ed. New York, McGraw-Hill, 1982, pp 973–1000

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Publishing Corporation

About this chapter

Cite this chapter

New, M.I. (1987). Female Pseudohermaphroditism in 21-Hydroxylase Deficiency. In: Gold, J.J., Josimovich, J.B. (eds) Gynecologic Endocrinology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2157-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2157-6_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9272-2

  • Online ISBN: 978-1-4613-2157-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics